A former scientist at the National Institutes of Health (NIH) has filed a lawsuit against the Trump administration, alleging that her termination was illegal and retaliatory. Dr. Jeanne Marrazzo, who previously led the NIH’s National Institute of Allergy and Infectious Diseases, claims she was dismissed for raising concerns about significant cuts to crucial research projects that she argues jeopardize public health.
The lawsuit, submitted in federal court in Maryland, outlines that the NIH has made substantial cuts—totaling billions of dollars—since President Donald Trump took office in January 2017. These reductions bypassed standard scientific funding processes and included critical clinical trials aimed at testing treatments for cancer, neurological disorders, and various health issues. A recent report indicated that these cuts have impacted over 74,000 individuals involved in ongoing experiments.
Dr. Marrazzo was placed on administrative leave last spring after voicing her objections to NIH officials regarding the cuts. She contended that some of these reductions would endanger participants in clinical trials, while others, particularly those affecting infectious disease and vaccine research, posed broader risks to public health. The lawsuit suggests that her concerns were ignored, and she was subsequently terminated by Health Secretary Robert F. Kennedy Jr..
In September 2023, Marrazzo lodged a complaint with the U.S. Office of Special Counsel, citing whistleblower retaliation. Her lawsuit emphasizes the importance of protecting the rights of federal employees to expose potential abuse and fraud within the government. She stated, “This lawsuit is about protecting not just my right to expose abuse and fraud by our government but those rights for all federal employees, so we can safeguard essential public health priorities and the integrity of scientific research.”
As of now, a spokesperson for the Department of Health and Human Services has declined to comment on the ongoing litigation. The ramifications of this case could have significant implications for how research funding and employee protections are handled within federal agencies.
The situation at the NIH reflects broader tensions over research priorities and funding allocation during the Trump administration. The cuts have drawn criticism from various sectors, raising alarms about the potential impact on scientific advancement and public health outcomes.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
